The researcher points out, however, that the recommendation does not apply to everyone who is diagnosed with Covid-19. “The treatment is indicated only for those who are hospitalized and only under medical supervision. This is because if a person takes anticoagulants without need or guidance, they can bleed to death.”

1dwycrh5dihrm96ma5degs2hcsds16guxq Read also: 82% of Covid-19 patients lack vitamin D, says study

Anticoagulants and Covid-19: How the study worked

Patients of both sexes, with an average age of 60 years, who were admitted to the hospital with oxygen saturation equal to or less than 93%, participated in the clinical trial. The objective was to evaluate the effect of heparin on several possible outcomes of SARS-CoV-2 infection. In addition to reducing mortality, therefore, we sought to see whether the treatment would reduce the need for non-invasive ventilation (with a high-flow catheter or oxygen mask), intubation and admission to the Intensive Care Unit (ICU).